• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化患者家庭监测方案:实时无线家庭肺功能测定的试点研究——经验与障碍

A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers.

机构信息

Department of Respiratory Medicine, Erasmus University Medical Center, 's-Gravendijkwal 230, Rotterdam, 3015, CE, The Netherlands.

出版信息

Respir Res. 2018 May 29;19(1):105. doi: 10.1186/s12931-018-0810-3.

DOI:10.1186/s12931-018-0810-3
PMID:29843728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5975585/
Abstract

In idiopathic pulmonary fibrosis (IPF), home monitoring experiences are limited, not yet real-time available nor implemented in daily care. We evaluated feasibility and potential barriers of a new home monitoring program with real-time wireless home spirometry in IPF. Ten patients with IPF were asked to test this home monitoring program, including daily home spirometry, for four weeks. Measurements of home and hospital spirometry showed good agreement. All patients considered real-time wireless spirometry useful and highly feasible. Both patients and researchers suggested relatively easy solutions for the identified potential barriers regarding real-time home monitoring in IPF.

摘要

在特发性肺纤维化(IPF)中,家庭监测的经验有限,尚未实时提供,也未在日常护理中实施。我们评估了新的家庭监测计划的可行性和潜在障碍,该计划使用实时无线家庭肺量计进行 IPF 监测。十名 IPF 患者被要求测试该家庭监测计划,包括四周的日常家庭肺量计测试。家庭和医院肺量计的测量结果显示出良好的一致性。所有患者均认为实时无线肺量计有用且高度可行。患者和研究人员均针对 IPF 实时家庭监测的已识别潜在障碍提出了相对简单的解决方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a558/5975585/438af931be81/12931_2018_810_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a558/5975585/6ad39e5a4042/12931_2018_810_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a558/5975585/438af931be81/12931_2018_810_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a558/5975585/6ad39e5a4042/12931_2018_810_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a558/5975585/438af931be81/12931_2018_810_Fig2_HTML.jpg

相似文献

1
A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers.特发性肺纤维化患者家庭监测方案:实时无线家庭肺功能测定的试点研究——经验与障碍
Respir Res. 2018 May 29;19(1):105. doi: 10.1186/s12931-018-0810-3.
2
Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.特发性肺纤维化患者的家庭监测。一项随机对照试验。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):393-401. doi: 10.1164/rccm.202002-0328OC.
3
Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis.家庭监测可提高特发性肺纤维化的终点效率。
Eur Respir J. 2017 Jul 5;50(1). doi: 10.1183/13993003.02406-2016. Print 2017 Jul.
4
A pilot study to monitor changes in spirometry and lung volume, following an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), as part of a supported discharge program.一项试点研究,旨在监测慢性阻塞性肺疾病(COPD)急性加重后肺活量测定和肺容积的变化,作为支持性出院计划的一部分。
Respir Med. 2016 Oct;119:55-62. doi: 10.1016/j.rmed.2016.08.019. Epub 2016 Aug 24.
5
Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis.每日家庭肺量计检查:检测特发性肺纤维化病情进展的有效工具。
Am J Respir Crit Care Med. 2016 Oct 15;194(8):989-997. doi: 10.1164/rccm.201511-2152OC.
6
Using forced vital capacity (FVC) in the clinic to monitor patients with idiopathic pulmonary fibrosis (IPF): pros and cons.用用力肺活量(FVC)在临床上监测特发性肺纤维化(IPF)患者:利弊。
Expert Rev Respir Med. 2021 Feb;15(2):175-181. doi: 10.1080/17476348.2020.1816831. Epub 2020 Sep 28.
7
Feasibility and acceptability of remotely monitoring spirometry and pulse oximetry as part of interstitial lung disease clinical care: a single arm observational study.远程监测肺量计和脉搏血氧饱和度作为间质性肺疾病临床护理一部分的可行性和可接受性:一项单臂观察性研究。
Respir Res. 2024 Apr 15;25(1):162. doi: 10.1186/s12931-024-02787-1.
8
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis.支气管扩张剂对特发性肺纤维化患者用力肺活量测量的影响。
Respir Med. 2015 Aug;109(8):1058-62. doi: 10.1016/j.rmed.2015.06.012. Epub 2015 Jun 24.
9
Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial.特发性肺纤维化患者的家庭肺量计检查:INMARK 试验的数据。
Eur Respir J. 2021 Jul 8;58(1). doi: 10.1183/13993003.01518-2020. Print 2021 Jul.
10
The effect of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a feasibility study.步行自行车对特发性肺纤维化患者生活质量和运动能力的影响:一项可行性研究。
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):192-202. doi: 10.36141/svdld.v37i2.9433. Epub 2020 Jun 30.

引用本文的文献

1
Comparing Approaches to Teaching Patients How to Use an App-Based Home Spirometer: Randomized Controlled Trial.比较教患者如何使用基于应用程序的家用肺活量计的方法:随机对照试验。
JMIR Form Res. 2025 Aug 14;9:e74125. doi: 10.2196/74125.
2
Monitoring respiratory function with telemedicine devices in asthmatic children.使用远程医疗设备监测哮喘儿童的呼吸功能。
Front Med (Lausanne). 2025 Jun 17;12:1604909. doi: 10.3389/fmed.2025.1604909. eCollection 2025.
3
Home Monitoring in Interstitial Lung Disease: Protocol for a Real-World Observational Study.

本文引用的文献

1
Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis.采用每日家庭肺量计检测新治疗的结节病患者早期类固醇治疗效果。
Eur Respir J. 2018 Jan 18;51(1). doi: 10.1183/13993003.02089-2017. Print 2018 Jan.
2
Development and feasibility of an eHealth tool for idiopathic pulmonary fibrosis.一种用于特发性肺纤维化的电子健康工具的开发与可行性研究
Eur Respir J. 2018 Mar 29;51(3). doi: 10.1183/13993003.02508-2017. Print 2018 Mar.
3
Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis.
间质性肺疾病的家庭监测:一项真实世界观察性研究的方案
JMIR Res Protoc. 2025 Jun 12;14:e65339. doi: 10.2196/65339.
4
Home spirometry telemonitoring in pediatric patients with asthma: a mixed study.哮喘儿科患者的家庭肺功能仪远程监测:一项混合研究。
Front Pediatr. 2025 May 14;13:1554921. doi: 10.3389/fped.2025.1554921. eCollection 2025.
5
The role of digital health in respiratory diseases management: a narrative review of recent literature.数字健康在呼吸系统疾病管理中的作用:近期文献综述
Front Med (Lausanne). 2025 Feb 26;12:1361667. doi: 10.3389/fmed.2025.1361667. eCollection 2025.
6
The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial.添加兰索拉唑治疗特发性肺纤维化患者的有效性和风险(TIPAL):一项随机安慰剂对照多中心临床试验的研究方案
BMJ Open. 2025 Feb 5;15(2):e088604. doi: 10.1136/bmjopen-2024-088604.
7
European ILD registry algorithm for self-assessment in interstitial lung diseases (eurILDreg ASA-ILD).欧洲间质性肺疾病自我评估注册算法(eurILDreg ASA-ILD)
PLoS One. 2025 Jan 29;20(1):e0316484. doi: 10.1371/journal.pone.0316484. eCollection 2025.
8
Interventions to improve quality of life and knowledge in Hypersensitivity Pneumonitis, a survey of clinician practices and perspectives.改善变应性肺炎患者生活质量和知识水平的干预措施:临床医生实践与观点调查
CHEST Pulm. 2024 Dec;2(4). doi: 10.1016/j.chpulm.2024.100083. Epub 2024 Jul 6.
9
Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement.成人慢性肺病家庭监测评估:美国胸科学会官方研究声明
Am J Respir Crit Care Med. 2025 Feb;211(2):174-193. doi: 10.1164/rccm.202410-2080ST.
10
Pilot study of home-based monitoring for early prediction of acute exacerbations in patients with fibrosing interstitial lung diseases.纤维化间质性肺疾病患者急性加重早期预测的家庭监测初步研究。
Sci Rep. 2024 Sep 10;14(1):21101. doi: 10.1038/s41598-024-71942-x.
家庭监测可提高特发性肺纤维化的终点效率。
Eur Respir J. 2017 Jul 5;50(1). doi: 10.1183/13993003.02406-2016. Print 2017 Jul.
4
Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis.每日家庭肺量计检查:检测特发性肺纤维化病情进展的有效工具。
Am J Respir Crit Care Med. 2016 Oct 15;194(8):989-997. doi: 10.1164/rccm.201511-2152OC.
5
The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire.《国王简短间质性肺病(K-BILD)健康状况问卷的制定与验证》。
Thorax. 2012 Sep;67(9):804-10. doi: 10.1136/thoraxjnl-2012-201581. Epub 2012 May 3.
6
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.特发性肺纤维化:诊断和管理的循证指南(美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会联合发布)
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
7
EuroQol: the current state of play.欧洲生活质量量表:当前进展情况
Health Policy. 1996 Jul;37(1):53-72. doi: 10.1016/0168-8510(96)00822-6.
8
The hospital anxiety and depression scale.医院焦虑抑郁量表。
Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.